Thursday, 6 October 2016

Global Pharmaceutical Rapid Microbiology Testing Market is expanding at a CAGR of 7.3% from 2016 to 2022

According to the latest report published by Credence Research, Inc. “Pharmaceutical Rapid Microbiology Testing Market – (Technology Type – Immunology based Methods, Nucleic acid based amplification tests, Mass Spectrometry based Methods, Flow Cytometry based Methods, Growth-based detection technologies, and Biochemical Tests; Application – Raw Material testing, In-Process testing, Microbial limit testing, Bioburden assessment, Process water testing, environment monitoring and sterility testing): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  market was valued at USD 3.4 Bn in 2015, and is expected to reach USD 6.2 Bn by 2022, expanding at a CAGR of 7.3% from 2016 to 2022.
Market Insights :
Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical application as well as in other industrial settings. In addition, rapid microbiology tests offer faster and more accurate methods to assist in the rapid detection of microbes and early diagnosis, thus saving cost and inventory.
Browse the full report Pharmaceutical Rapid Microbiology Testing Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report athttp://www.credenceresearch.com/report/pharmaceutical-rapid-microbiology-testing-market
North America held the largest regional market, accounting for the market share of over 36% in 2015, and is anticipated to dominate the global rapid microbiology tests market during the forecast period 2016 to 2022.  Large numbers of market-focused players providing wider range of product portfolio are the key to growth of the North America region. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to increase in the number of laboratories in these regions and up gradation of existing ones for automation of various instrumentation systems. Moreover, the market is wide open for advancing rapid diagnostic technologies to improve the turnaround time of the tests as compared to the conventional microbiology testing methods.
Among the technology types, nucleic acid amplification technique held the largest share in the rapid microbiology tests in the pharmaceutical industry market due to its low cost and high efficacy. Moreover, the wide applications of nucleic acid amplification testing would further fuel the market growth in the coming years. Growth based detection technologies are anticipated to grow at a highest growth rate during the forecast period due to its faster turnaround time and accuracy in the detection of the microbes.
The sterility testing application held the largest share in the global rapid microbiology tests in pharmaceutical market due its wide application in the final drug product and other applications. Process water testing is anticipated to witness the highest growth in the global rapid microbiology tests in the pharmaceutical industry market during the forecast period of 2016 to 2022.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Saline Laxatives Market is expected to reach USD 490.5 Mn by 2022,Credence Research

According to the latest report published by Credence Research, Inc. “Global Saline Laxatives(Magnesium Citrate, Magnesium Hydroxide, Sodium Phosphates; Prescribed and OTC Drugs) Market – Growth, Future Prospects and Competitive Assessment, 2016 – 2022,” the saline laxatives market was valued at USD 303.6 Mn in 2015, and is expected to reach USD 490.5 Mn by 2022, expanding at a CAGR of 8.3% from 2016 to 2022.
Market Insights 
Saline laxatives are osmotic laxatives that work by drawing fluids into the bowel from surrounding tissue, thus softening stools and assist in easy fecal discharge. Saline laxatives are largely used for swift emptying of bowels to prepare for examination or surgery, eliminating drugs and food during poisoning or overdose and obtaining fresh stool sample for testing. These drugs are distinct from conventional bulk forming laxatives and hence are not usually used for treating constipation.
Browse the full report Global Saline Laxatives Market – Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report @ http://www.credenceresearch.com/report/saline-laxatives-market
The global saline laxatives market is anticipated to witness a steady progress during the forecast period due to high demand for and wide availability of these products over-the-counter. Non-prescribed use of saline laxatives for immediate weight loss is also common. The demand for saline laxatives is widely witnessed in senescent population, where immediate and regular voiding of bowel is a prime usage factor. Hence, abuse of saline laxatives is predominantly found in this age group, particularly in the developed markets where awareness about the range of available laxatives is high.
Magnesium Citrate, Magnesium Hydroxide and Sodium Phosphates are the major saline laxatives. Brands such as Phillips’ Milk of Magnesia, OsmoPrep, Fleet Enema, Phillips’ M-O, Ceo-Two are some of the major names in the global market. Since magnesium and phosphate are the key ingredients in saline laxatives, their use is discouraged to use in patients with renal failure. Reported adverse effects such as nephrocalcinosis, acute phosphate nephropathy, and renal failure associated with excessive use of oral sodium phosphates has urged the USFDA to issue warning with respect to unsolicited use of such drugs.
The overall saline laxatives market is moderately competitive, and is characterized with existence of some key brands that monopolize the market. Some of the major players in this space are Beutlich Pharmaceuticals, LLC, C.B. Fleet Company, Inc., Salix Pharmaceuticals, Bayer AG and others.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Plant Stem Cell Market for nutrition is expected to reach USD 1,299.7 Mn by 2022, Credence Research

The latest market report published by Credence Research, Inc. “Global Plant Stem Cell Market for Nutrition – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the plant stem cell market for nutrition was valued at USD 324.0 Mn in 2015, and is expected to reach USD 1,299.7 Mn by 2022, expanding at a CAGR of 21.3% from 2016 to 2022.
Market Insights:
Plant Stem Cell remedies, also called gemmotherapy, are the extracts from the buds and shoots of plants, trees, and shrubs. The remedies are extracted by a highly specialized process using alcohol, water, and glycerin to extract the full spectrum of phytochemicals. There are two parts within a plant stem cell remedy that are important in its healing effect: the plant growth hormones and the phytochemicals. The plant growth hormones stimulate immature cells in the tissues and organs in human body and repair damaged cells.
Browse the full report Plant Stem Cell Market for Nutrition – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report athttp://www.credenceresearch.com/report/plant-stem-cell-market-for-nutrition
While, phytochemicals in plant stem cell remedies promote regeneration through stimulating cellular processes and can aid in many different metabolism pathways within the body. Plant stem cell technology is a key group in this area that is witnessing significant research activities and awareness in consumer group. Plant stem cell technology is claimed to control and even reverse ageing process by harnessing the regenerative power of stem cells. This technology also helps in improving human stem cell regeneration. The earliest plant stem cell explored for anti-aging is from Swiss apples. At present stem cells Edelweiss, grape, argan, coneflower and other such miracle fruits and plants are increasingly being adopted in the novel advanced skin care and wellness products. Plant stem cell extracts helps fight infections and detoxifies toxins that cause chronic illnesses. Plant stem cells in nutrition is a developing segment in the field of biotechnology, and is expected to grow in the forecast period due to its increasing application in acute as well as chronic diseases. Moreover, rising application of plant stem cells in the day-to-day well would further fuel the market growth in the near future.
Market Competition Assessment:
The plant stem cell market for nutrition is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Mibelle Group, Aidan Products LLC, PhytoScience SdnBhd, PSC Distribution LLC, Natura Therapeutics, Inc., and others.
Key Market Movements:
  • Spending on agricultural and nutrition research and development has increased recently but the rate of growth is slow than expected
  • As of the present market scenario, products with plant stem cells with key ingredients are rare as against supplements with key nutrient ingredients that boost body stem cell regeneration
  • Affordability associated with these processes is in the capacity of the nutrition companies, where research in academia is restricted to funding and donations. As a result, the end-products thus introduced in the market are high priced
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Tuesday, 4 October 2016

Wound Care Market is expected to expanding at a CAGR of 4.3% from 2016 to 2022, Credence Research

According to the latest report published by Credence Research, Inc. “Wound Care Market – (Product Type – Advanced Wound Closure: Haemostatic and Sealing Agent, Topical Tissue Adhesive, and Wound Closure Devices, Advanced Wound care: Moist Wound Dressings, Active Wound Care, and Therapy Devices; Application – Chronic Wounds, and Acute Wounds) :Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  market was valued at USD 14.6 Bn in 2015, and is expected to reach USD 19.8 Bn by 2022, expanding at a CAGR of 4.3% from 2016 to 2022.
Market Insights
The global wound care market involves various products that help in healing and preventing infection. Wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal and take substantial time to heal. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds. North America held the largest regional market, accounting for the share of over 35% in 2015, and is anticipated to dominate the global wound care market during the forecast period of 2016 to 2022. Rising geriatric population susceptible for diabetes and rising volume of surgical procedures would also assist the wound care market in North America. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to growing medical investments and healthcare infrastructure in Asia Pacific, especially in the countries such as China, Japan and India.
Browse the full report Wound Care Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/wound-care-market
The advance wound closure products held the largest market in the global wound care market. Rising lifestyle diseases that lead to chronic wounds such as diabetic foot ulcers and growing number of cosmetic, plastic and other surgical procedures has boosted the market growth. The advance wound care product is anticipated to grow at a faster rate due to the growing awareness about wound management and effectiveness of the products.
The chronic wound market held the largest segment in the global wound care market. The diabetic foot ulcer treatment held the largest share in the chronic wound segment. Rising number of diabetes cases globally is the major driver for the growth of this market. The acute wounds market is expected to grow at a faster rate due to the rising number surgical and traumatic cases in the world, driving the wound care market.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290

Posted by at No comments:
Labels:

Global Hyaluronic Acid Products Market is Expected to Reach USD 10,901.5 Mn by 2022 – Credence Research

The latest market report published by Credence Research, Inc. “Global Hyaluronic Acid Products Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the Hyaluronic Acid Products market was valued at USD 6,362.5 Mn in 2015, and is expected to reach USD 10,901.5 Mn by 2022, expanding at a CAGR of 8.1% from 2016 to 2022.
Market Insights:
Hyaluronic Acid Products, also known as hyaluronate or hyaluron is widely available in injectable, capsule and skin creams. Hyaluronic Acid Products has water retention properties thus acts as a pace filler and cushioning agent in mammals. Hyaluronic Acid Products cushions joints and tissue, hydrates hair and skin and fills eyes. Despite discovered in 1934, its mainstream cosmetic and healthcare application is only recent. The overall Hyaluronic Acid Products market is experiencing impressive progress worldwide due to factors such as growing awareness, aging population, growing demand for aesthetic and anti-aging products and growing demand for minimally invasive procedures. Introduction of novel products such as single-injection and VUX application and penetration in untapped regional markets of Asia-Pacific and Middle East and Africa are the major growth areas in the Hyaluronic Acid Products market.
Browse the full report Hyaluronic Acid Products Market at http://www.credenceresearch.com/report/hyaluronic-acid-products-market
Among the various product types, single injections are premium priced hyaluron products and are in significant demand in Europe and North America markets. Products such as three- and five-injections have high potential in emerging regions of Asia-Pacific. The demand for dermal fillers and hyaluron for osteoarthritis treatment are the major areas where the Hyaluronic Acid Products market will witness significant growth.
Market Competition Assessment:
The Hyaluronic Acid Products market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Anika Therapeutics, Inc., Allergan, Inc., Sanofi S.A., Ferring B.V., Seikagaku Corporation, Salix Pharmaceutical, Fidia Farmaceutici, Zimmer Biomet.
Key Market Movements:
  • Significant growth in senescent population pool is expected to drive the overall Hyaluronic Acid Products market growth
  • Growing target patient population worldwide will propel the demand for Hyaluronic Acid Products in orthopedic and anti-aging treatments
  • Growing trend for minimally invasive procedures in aesthetics and therapeutics
  • Anti-aging market in particular is witnessing intensive product development and commercialization. Currently experienced efficacy and safety issues associated with Hyaluronic Acid Products are a key area where further exploration is in process
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)